BioCentury
ARTICLE | Company News

Myriad Genetics, Saladax sales and marketing update

February 18, 2013 8:00 AM UTC

Saladax said Myriad will return North American rights to its My5-FU diagnostic test following a pipeline evaluation. Saladax said Myriad, which had marketed the test as OnDose, will return rights wh...